Solid lipid nanoparticles for ocular delivery of isoniazid: evaluation, proof of concept and in vivo safety & kinetics
| dc.contributor.author | Srinivas, C.S. | |
| dc.date.accessioned | 2020-11-26T04:16:27Z | |
| dc.date.available | 2020-11-26T04:16:27Z | |
| dc.date.issued | 2019 | |
| dc.description | Only IISERM authors are available in the record. | |
| dc.description.abstract | Abstract not available | en_US |
| dc.identifier.citation | Nanomedicine,14(4),pp.465-491. | en_US |
| dc.identifier.other | https://doi.org/10.2217/nnm-2018-0278 | |
| dc.identifier.uri | https://www.futuremedicine.com/doi/full/10.2217/nnm-2018-0278 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/2231 | |
| dc.language.iso | en | en_US |
| dc.publisher | Future Medicine | en_US |
| dc.subject | Cellular uptake | en_US |
| dc.subject | Corneal permeability | en_US |
| dc.subject | Cytotoxicity | en_US |
| dc.subject | In vitro release | en_US |
| dc.title | Solid lipid nanoparticles for ocular delivery of isoniazid: evaluation, proof of concept and in vivo safety & kinetics | en_US |
| dc.type | Article | en_US |